PURPOSE: Retinal hemorrhages occur in a variety of sight-threatening conditions including ocular trauma, high altitude retinopathy, and chronic diseases such as diabetic and hypertensive retinopathies. The goal of this study is to investigate the effects of blood in the vitreous on retinal vascular function in rats. METHODS: Intravitreal injections of autologous blood, plasma kallikrein (PK), bradykinin, and collagenase were performed in Sprague-Dawley and Long-Evans rats. Retinal vascular permeability was measured using vitreous fluorophotometry and Evans blue dye permeation. Leukostasis was measured by fluorescein isothiocyanate-coupled concanavalin A lectin and acridine orange labeling. Retinal hemorrhage was examined on retinal flatmounts. Primary cultures of bovine retinal pericytes were cultured in the presence of 25 nM PK for 24 hours. The pericyte-conditioned medium was collected and the collagen proteome was analyzed by tandem mass spectrometry. RESULTS: Intravitreal injection of autologous blood induced retinal vascular permeability and retinal leukostasis, and these responses were ameliorated by PK inhibition. Intravitreal injections of exogenous PK induced retinal vascular permeability, leukostasis, and retinal hemorrhage. Proteomic analyses showed that PK increased collagen degradation in pericyte-conditioned medium and purified type IV collagen. Intravitreal injection of collagenase mimicked PK's effect on retinal hemorrhage. CONCLUSIONS: Intraocular hemorrhage increases retinal vascular permeability and leukostasis, and these responses are mediated, in part, via PK. Intravitreal injections of either PK or collagenase, but not bradykinin, induce retinal hemorrhage in rats. PK exerts collagenase-like activity that may contribute to blood-retinal barrier dysfunction.
PURPOSE:Retinal hemorrhages occur in a variety of sight-threatening conditions including ocular trauma, high altitude retinopathy, and chronic diseases such as diabetic and hypertensive retinopathies. The goal of this study is to investigate the effects of blood in the vitreous on retinal vascular function in rats. METHODS: Intravitreal injections of autologous blood, plasma kallikrein (PK), bradykinin, and collagenase were performed in Sprague-Dawley and Long-Evans rats. Retinal vascular permeability was measured using vitreous fluorophotometry and Evans blue dye permeation. Leukostasis was measured by fluorescein isothiocyanate-coupled concanavalin A lectin and acridine orange labeling. Retinal hemorrhage was examined on retinal flatmounts. Primary cultures of bovine retinal pericytes were cultured in the presence of 25 nM PK for 24 hours. The pericyte-conditioned medium was collected and the collagen proteome was analyzed by tandem mass spectrometry. RESULTS: Intravitreal injection of autologous blood induced retinal vascular permeability and retinal leukostasis, and these responses were ameliorated by PK inhibition. Intravitreal injections of exogenous PK induced retinal vascular permeability, leukostasis, and retinal hemorrhage. Proteomic analyses showed that PK increased collagen degradation in pericyte-conditioned medium and purified type IV collagen. Intravitreal injection of collagenase mimicked PK's effect on retinal hemorrhage. CONCLUSIONS: Intraocular hemorrhage increases retinal vascular permeability and leukostasis, and these responses are mediated, in part, via PK. Intravitreal injections of either PK or collagenase, but not bradykinin, induce retinal hemorrhage in rats. PK exerts collagenase-like activity that may contribute to blood-retinal barrier dysfunction.
Authors: Annika Armulik; Guillem Genové; Maarja Mäe; Maya H Nisancioglu; Elisabet Wallgard; Colin Niaudet; Liqun He; Jenny Norlin; Per Lindblom; Karin Strittmatter; Bengt R Johansson; Christer Betsholtz Journal: Nature Date: 2010-10-13 Impact factor: 49.962
Authors: Ben-Bo Gao; Allen Clermont; Susan Rook; Stephanie J Fonda; Vivek J Srinivasan; Maciej Wojtkowski; James G Fujimoto; Robert L Avery; Paul G Arrigg; Sven-Erik Bursell; Lloyd Paul Aiello; Edward P Feener Journal: Nat Med Date: 2007-01-28 Impact factor: 53.440
Authors: Chris Oschatz; Coen Maas; Bernd Lecher; Thomas Jansen; Jenny Björkqvist; Thomas Tradler; Reinhard Sedlmeier; Peter Burfeind; Sven Cichon; Sven Hammerschmidt; Werner Müller-Esterl; Walter A Wuillemin; Gunnar Nilsson; Thomas Renné Journal: Immunity Date: 2011-02-25 Impact factor: 31.745
Authors: Alexey S Revenko; Dacao Gao; Jeff R Crosby; Gourab Bhattacharjee; Chenguang Zhao; Chris May; David Gailani; Brett P Monia; A Robert MacLeod Journal: Blood Date: 2011-08-05 Impact factor: 22.113
Authors: Leif R Lund; Kirsty A Green; Allart A Stoop; Michael Ploug; Kasper Almholt; Jennifer Lilla; Boye S Nielsen; Ib J Christensen; Charles S Craik; Zena Werb; Keld Danø; John Rømer Journal: EMBO J Date: 2006-06-08 Impact factor: 11.598
Authors: John S Penn; Gary W McCollum; Joshua M Barnett; Xiang Q Werdich; Katherine A Koepke; Veera S Rajaratnam Journal: Invest Ophthalmol Vis Sci Date: 2006-01 Impact factor: 4.799
Authors: Daniel Barthelmes; Martina M Bosch; Tobias M Merz; Benno L Petrig; Frederic Truffer; Konrad E Bloch; Timothy A Holmes; Philippe Cattin; Urs Hefti; Miriam Sellner; Florian K P Sutter; Marco Maggiorini; Klara Landau Journal: PLoS One Date: 2011-02-17 Impact factor: 3.240
Authors: Jia Liu; Ben-Bo Gao; Allen C Clermont; Price Blair; Tamie J Chilcote; Sukanto Sinha; Robert Flaumenhaft; Edward P Feener Journal: Nat Med Date: 2011-01-23 Impact factor: 53.440
Authors: V G Madanagopalan; C K Nagesha; Girish Velis; Santosh Devulapally; S Balamurugan Journal: Indian J Ophthalmol Date: 2018-07 Impact factor: 1.848
Authors: Jian Guan; Allen C Clermont; Loc-Duyen Pham; Tuna Ustunkaya; Alexey S Revenko; A Robert MacLeod; Edward P Feener; Fabrício Simão Journal: Transl Stroke Res Date: 2021-07-09 Impact factor: 6.829